ShareHope Medicine Co., Ltd. (8403.TWO)
TWD 28.6
(-0.17%)
TWD 28.6
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 257.13 Million | 642.46 Million | 360.1 Million | 717.73 Million | - |
| Net Income | 108.98 Million | 339.93 Million | 267.62 Million | 479.09 Million | - |
| Depreciation & Amortization | 320.57 Million | 307.14 Million | 304.52 Million | 216.38 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | 3.26 Million | 31.21 Million | - |
| Change in working capital | -90.11 Million | 63.99 Million | -73.21 Million | -24.63 Million | - |
| Other non-cash items | 44.84 Million | 35.62 Million | 18.38 Million | 13.09 Million | - |
| Investing Cash Flow | -227.6 Million | -1.37 Billion | -320.7 Million | -393.77 Million | - |
| Investments in PPE | -277.2 Million | -1.28 Billion | -152.26 Million | -364 Million | - |
| Acquisitions | -12 Million | -73.9 Million | 7.5 Million | -2.55 Million | - |
| Investment purchases | -58.02 Million | -139.95 Million | -137.64 Million | -27.36 Million | - |
| Sales/Maturities of investments | 97.87 Million | 32.36 Million | 85.05 Million | 9.38 Million | - |
| Other Investing Activities | -20.71 Million | -21.52 Million | -130.93 Million | -17.51 Million | - |
| Financing Cash Flow | -180.38 Million | 706.28 Million | -163.4 Million | 321.47 Million | - |
| Debt repayment | -228.72 Million | -872.36 Million | -151.39 Million | -82.28 Million | - |
| Dividends payments | -62.44 Million | -59.32 Million | -102.8 Million | - | -48.71 Million |
| Common Stock Repurchased | -227.43 Million | - | -102.8 Million | -2.11 Million | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 1.31 Million | 18.04 Million | 202.08 Million | 312.91 Million | - |
| Accounts receivables | -147.31 Million | - | - | - | - |
| Accounts payables | 44.07 Million | - | - | - | - |
| Inventory | -517 Thousand | 18.84 Million | 40.62 Million | -90.12 Million | - |
| Other working capital | 6.6 Million | - | - | - | - |
| Cash at beginning of period | 1.53 Billion | 1.55 Billion | 1.68 Billion | 1.04 Billion | - |
| Cash at end of period | 1.38 Billion | 1.53 Billion | 1.55 Billion | 1.68 Billion | - |
| Capital Expenditure | -277.2 Million | -1.28 Billion | -152.26 Million | -364 Million | - |
| Effect of forex changes on cash | -1.3 Million | 2.83 Million | -5.36 Million | -2.5 Million | - |
| Net cash flow / Change in cash | -152.16 Million | -21.99 Million | -129.37 Million | 642.93 Million | - |
| Free Cash Flow | -20.07 Million | -641.58 Million | 207.84 Million | 353.73 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 64.69 Million | 24.38 Million | 108.98 Million | 46.34 Million | 7.04 Million | 28.51 Million |
| Depreciation & Amortization | 78.4 Million | 79.56 Million | 320.57 Million | 79.55 Million | 81.93 Million | 82.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 57.24 Million | -61.44 Million | -90.11 Million | -32.05 Million | 59.68 Million | 50.36 Million |
| Other non-cash items | 10.05 Million | 13.14 Million | 44.84 Million | 10.02 Million | 11.92 Million | 11.33 Million |
| Investing Cash Flow | 72.3 Million | -86.49 Million | -227.6 Million | -70.98 Million | -67.56 Million | -11.49 Million |
| Investments in PPE | -7.79 Million | -28.15 Million | -277.2 Million | -81.81 Million | -31.3 Million | -44.38 Million |
| Acquisitions | 56.99 Million | - | -12 Million | - | -2 Million | - |
| Investment purchases | -11 Million | -59.41 Million | -58.02 Million | -12.55 Million | -27.22 Million | -2.55 Million |
| Sales/Maturities of investments | - | 1.48 Million | 97.87 Million | 187 Thousand | - | 21.41 Million |
| Other Investing Activities | 822 Thousand | -2.87 Million | -20.71 Million | -14.63 Million | -9.22 Million | 11.63 Million |
| Financing Cash Flow | -45.99 Million | -69.28 Million | -180.38 Million | 55.48 Million | -61.74 Million | -309.94 Million |
| Debt repayment | -16.27 Million | -40.6 Million | -228.72 Million | -82.95 Million | -27.09 Million | -69.58 Million |
| Dividends payments | - | - | -62.44 Million | - | -60.02 Million | - |
| Common Stock Repurchased | - | - | -227.43 Million | - | - | -203.04 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -581 Thousand | 1.95 Million | 1.31 Million | -901 Thousand | 57 Thousand | -129 Thousand |
| Accounts receivables | -47.38 Million | - | - | - | - | - |
| Accounts payables | 146.63 Million | - | - | - | - | - |
| Inventory | -13.45 Million | 10.23 Million | -517 Thousand | 20.73 Million | 6.87 Million | -7.58 Million |
| Other working capital | -29.09 Million | - | - | - | - | - |
| Cash at beginning of period | 1.26 Billion | 1.38 Billion | 1.53 Billion | 1.29 Billion | 1.3 Billion | 1.52 Billion |
| Cash at end of period | 1.39 Billion | 1.26 Billion | 1.38 Billion | 1.38 Billion | 1.29 Billion | 1.3 Billion |
| Capital Expenditure | -7.79 Million | -28.15 Million | -277.2 Million | -81.81 Million | -31.3 Million | -44.38 Million |
| Effect of forex changes on cash | 419 Thousand | 1.14 Million | -1.3 Million | -3.24 Million | 2.45 Million | -617 Thousand |
| Net cash flow / Change in cash | 131.21 Million | -118.99 Million | -152.16 Million | 85.27 Million | -7.44 Million | -214.85 Million |
| Free Cash Flow | 96.69 Million | 7.49 Million | -20.07 Million | 22.2 Million | 88.09 Million | 62.82 Million |
JAWA
ACT
CHFLF
3093
PRCT
FCPB